Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Catherine A. Egan"'
Autor:
Emily Y. Chew, MD, Tunde Peto, MD, PhD, Traci E. Clemons, PhD, Ferenc B. Sallo, MD, PhD, Daniel Pauleikhoff, MD, PhD, Irene Leung, BA, Glenn J. Jaffe, MD, Tjebo F.C. Heeren, MD, Catherine A. Egan, MD, Peter Charbel Issa, MD, PhD, Konstantinos Balaskas, MD, Frank G. Holz, MD, Alain Gaudric, MD, Alan C. Bird, MD, Martin Friedlander, MD, PhD
Publikováno v:
Ophthalmology Science, Vol 3, Iss 2, Pp 100261- (2023)
Purpose: To develop a severity classification for macular telangiectasia type 2 (MacTel) disease using multimodal imaging. Design: An algorithm was used on data from a prospective natural history study of MacTel for classification development. Subjec
Externí odkaz:
https://doaj.org/article/8e52d23d291641379d3db5dc7d920159
Autor:
Roberto Bonelli, Victoria E. Jackson, Aravind Prasad, Jacob E. Munro, Samaneh Farashi, Tjebo F. C. Heeren, Nikolas Pontikos, Lea Scheppke, Martin Friedlander, MacTel Consortium, Catherine A. Egan, Rando Allikmets, Brendan R. E. Ansell, Melanie Bahlo
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Melanie Bahlo and colleagues report a genome-wide association study on the retinal degenerative disease Macular Telangiectasia Type 2, identifying 8 new genome-wide significant loci. Further analyses suggest key roles for genes that transport and syn
Externí odkaz:
https://doaj.org/article/9cba7a84572b4acc832cac9a6d05482a
Autor:
Mali Okada, Catherine A. Egan, Tjebo FC. Heeren, Philippe Valmaggia, Adnan Tufail, Peter M. Maloca
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 25, Iss , Pp 101267- (2022)
Purpose: To visualize the mode of action of anti-vascular endothelial growth factor (anti-VEGFs) therapy on retinal neovascularization (RNV) in a patient with macular telangiectasia (MacTel) type 2 using a detailed three-dimensional data environment.
Externí odkaz:
https://doaj.org/article/5523715ea8764b5bbd7287e85af79984
Autor:
Baixiang Xiao, Gareth D. Mercer, Ling Jin, Han Lin Lee, Tingting Chen, Yanfang Wang, Yuanping Liu, Alastair K. Denniston, Catherine A. Egan, Jia Li, Qing Lu, Ping Xu, Nathan Congdon
Publikováno v:
PLoS ONE, Vol 17, Iss 4 (2022)
Importance Poor access to existing care for diabetic retinopathy (DR) limits effectiveness of proven treatments. Objectives We examined whether outreach screening in rural China improves equity of access. Design, setting and participants We compared
Externí odkaz:
https://doaj.org/article/3f699399be9e486f89e700c58ca38a25
Autor:
Roberto Bonelli, Victoria E. Jackson, Aravind Prasad, Jacob E. Munro, Samaneh Farashi, Tjebo F. C. Heeren, Nikolas Pontikos, Lea Scheppke, Martin Friedlander, MacTel Consortium, Catherine A. Egan, Rando Allikmets, Brendan R. E. Ansell, Melanie Bahlo
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-1 (2021)
A Correction to this paper has been published: https://doi.org/10.1038/s42003-021-01972-y
Externí odkaz:
https://doaj.org/article/8e9e260332a94a1b9593ace90158e3ba
Autor:
Dawn A. Sim, Colin J. Chu, Senthil Selvam, Michael B. Powner, Sidath Liyanage, David A. Copland, Pearse A. Keane, Adnan Tufail, Catherine A. Egan, James W. B. Bainbridge, Richard W. Lee, Andrew D. Dick, Marcus Fruttiger
Publikováno v:
Disease Models & Mechanisms, Vol 8, Iss 11, Pp 1479-1487 (2015)
We have developed a method to label and image myeloid cells infiltrating the mouse retina and choroid in vivo, using a single depot injection of indocyanine green dye (ICG). This was demonstrated using the following ocular models of inflammation and
Externí odkaz:
https://doaj.org/article/cf13bafe9f794190bea5ac616ccec9fb
Autor:
Abraham Olvera-Barrios, Christopher G. Owen, John Anderson, Alasdair Warwick, Ryan Chambers, Louis Bolter, Yue Wu, Roshan Welikala, Jiri Fajtl, Sarah Barman, Paolo Remagnino, Emily Y. Chew, Frederick L. Ferris, Aroon D. Hingorani, Reecha Sofat, Aaron Lee, Catherine A. Egan, Adnan Tufail, Alicja R. Rudnicka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ded0f31a50a6190673b237888edd0dbc
https://doi.org/10.2139/ssrn.4336087
https://doi.org/10.2139/ssrn.4336087
Autor:
Bobby Paul, Maria Pikoula, A. K. Patwardhan, Abraham Olvera-Barrios, Andrew J. Lotery, A Davis, Vineeth Kumar, Salim Natha, Toks Akerele, Carolyn J.P. Jones, Usha Chakravarthy, Paul Taylor, Roy Schwartz, Haralabos Eleftheriadis, Sudeshna Patra, Christopher Brand, Peck-Lin Lip, Richard J Antcliff, Aaron Y. Lee, Alasdair Warwick, Geeta Menon, Faruque Ghanchi, U. Chakravarthy, Clare Bailey, Elizabeth Wilkinson, Sajjad Mahmood, Louise Downey, Raj Mukherjee, Catherine A Egan, Spiros Denaxas, James S Talks, Peck Lin Lip, Aires Lobo, Rehna Khan, Narendra Dhingra, Sheena George, Helen Palmer, Adnan Tufail
Publikováno v:
Ophthalmol Retina
PURPOSE: Management of neovascular age-related macular degeneration (nAMD) has evolved over the last decade with several treatment regimens and different medications. This study describes the treatment patterns and, importantly, visual outcomes over
Autor:
Abraham Olvera-Barrios, Amit V Mishra, Roy Schwartz, Mumina Khatun, Michael Seltene, Celestine Rutkowska, Alicja R Rudnicka, Christopher G Owen, Adnan Tufail, Catherine A Egan
Publikováno v:
The British journal of ophthalmology.
AimsTo analyse the prevalence of visual impairment (VI), compare it to certification of visual impairment (CVI) and analyse VI associations in patients with diabetic retinopathy (DR).MethodsRetrospective cohort study, which included 8007 patients wit
Autor:
Philipp L. Müller, Paul Taylor, Roy Schwartz, Praveen J. Patel, Alasdair Warwick, Abraham Olvera-Barrios, Darren S. Thomas, Catherine A Egan, Aaron Y. Lee, Tjebo F. C. Heeren, Adnan Tufail
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 3, Pp 1166-1175 (2021)
Clinical and Translational Science, Vol 14, Iss 3, Pp 1166-1175 (2021)
One‐in‐four ophthalmology trials are single‐armed, which poses challenges to their interpretation. We demonstrate how real‐world cohorts used as external/synthetic control arms can contextualize such trials. We herein emulated a target trial